
Trump’s drug pricing order boosts case for generics and biosimilars: Kiran Mazumdar-Shaw
US President Donald Trump’s recent executive order to reduce prescription drug prices aims to address the significant price disparity of innovator drugs between the US and other developed markets like Europe and Australia. According to Biocon executive …